Photo of Paolo Boffetta

Paolo Boffetta

  • DIRECTOR INSTITUTE FOR TRANSLATIONAL EPIDEMIOLOGY
  • PROFESSOR Oncological Sciences
  • PROFESSOR Medicine, Hematology and Medical Oncology
  • PROFESSOR Preventive Medicine
Print ProfilePrint Profile

Education

  • MD, University of Turin

  • Internship, University Hospital Turin

  • MPH, Columbia University

Biography

    Dr. Boffetta moved to Mount Sinai School of Medicine in 2010.  He is Director of the Institute for Translational Epidemiology and Associate Director for Population Sciences of The Tisch Cancer Institute.  He is also the Bluhdorn Professor of International Community Medicine.

    Dr. Boffetta's previous employments include Columbia University (New York, NY), the American Cancer Society (New York, NY), the American Cancer Society (New York, NY), the International Agency for Research on Cancer (Lyon, France), and the German Cancer Research Center (Heidelberg, Germany).

    Dr. Boffetta is Adjunct Professor at the Department of Epidemiology, Harvard School of Public Health (Boston, MA), Visiting Professor at the Department of Biomedical Sciences and Human Oncology, University of Turin (Turin, Italy), Adjunct Professor at the Department of Medicine, Vanderbilt University (Nashville, TN), Affiliate Member of the R. Samuel McLaughlin Centre for Population Health Risk Assessment, University of Ottawa (Ottawa, Canada), Senior Fellow of the Hellenic Health Foundation (Athens, Greece), Honorary Professor at the College of Medicine, Dentistry and Nursing, University of Dundee (Dundee, United Kingdom), Adjunct Professor at Biodesign Institute, Arizona State University (Tempe, AZ), and Vice-President of the International Prevention Research Institute (Lyon, France).

    Dr. Boffetta is the author of over 700 peer-reviewed publications, mainly in the field of epidemiology of chronic diseases.  He has edited 15 books and authored over 80 book chapters.  He is associate editor of Lung Cancer, European Journal of Clinical Investigation, and Frontiers in Cancer Epidemiology, and is a member for more than 10 editorial boards of scientific journals.  He is the founding member of several international cancer epidemiology consortia and networks.

    Major Research Interests:

    • Molecular and genetic epidemiology
    • Cancer Epidemiology
    • Cardiovascular and diabetes epidemiology
    • Cancer prevention
    • Epidemiologic methods

    Read a press release on Dr. Boffetta's study of the relationship between high consumption of fruits and vegetables and risk of cancer.

    Watch a video from BMJ.com on tea drinking habits and oesophageal cancer in Iran.

Publications

Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F, Tamakoshi A, Gao YT, Wang R, Shu XO, Tsuji I, Kuriyama S, Tanaka H, Satoh H, Chen CJ, Yuan JM, Yoo KY, Ahsan H, Pan WH, Gu D, Pednekar MS, Sauvaget C, Sasazuki S, Sairenchi T, Yang G, Xiang YB, Nagai M, Suzuki T, Nishino Y, You SL, Koh WP, Park SK, Chen Y, Shen CY, Thornquist M, Feng Z, Kang D, Boffetta P, Potter JD. Association between body-mass index and risk of death in more than 1 million Asians. The New England journal of medicine 2011 Feb; 364(8).

Boffetta P, Colditz GA, Potter JD, Kolonel L, Robson PJ, Malekzadeh R, Seminara D, Goode EL, Yoo KY, Demers P, Gallagher R, Prentice R, Yasui Y, O'Doherty K, Petersen GM, Ulrich CM, Csizmadi I, Amankwah EK, Brockton NT, Kopciuk K, McGregor SE, Kelemen LE. Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009). Cancer causes & control : CCC 2011 Mar; 22(3).

Boffetta P, Jayaprakash V, Yang P, Asomaning K, Muscat JE, Schwartz AG, Zhang ZF, Le Marchand L, Cote ML, Stoddard SM, Morgenstern H, Hung RJ, Christiani DC. Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO). Cancer causes & control : CCC 2011 Jan; 22(1).

Boffetta P, Et Al . Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). . J Natl Cancer Inst 2010; 102: 529-537.

Sankaranarayanan R, Boffetta P. Research on cancer prevention, detection and management in low- and medium-income countries. . Ann Oncol. ; 2010(March 15).

McCormack V, A, Dahm C, Overvad K, Olsen A, Tjonneland A, Kaaks R, Boeing H, Manjer J, Almquist M, Hallmans G, Johansson I, Chirlaque M, Barricarte A, Dorronsoro M, Rodriguez L, Redondo M , Khaw K, Wareham N, Allen N , Key T, Riboli E, Boffetta P. Cigar and pipe smoking and cancer risk in the european prospective investigation into cancer and nutrition. . Int J Cancer. 2010 Feb 16;.

Boffetta P. Biomarkers in cancer epidemiology: an integrative approach. Carcinogenesis 2010 Jan; 31(1).

Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. . BMJ; 2009(339): b3060.

Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A , Konobeevskaya I, Igitov V V, Terechova T, Boffetta P, Peto R. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths.. Lancet 2009 2201; 373.

Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, Abedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet C, Brennan P, Møller H, Saidi F, Dawsey S, Malekzadeh R, Boffetta P. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. . BMJ 2009;(338): b929.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Boffetta during 2013 and/or 2014. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

  • ENVIRON Global; Eni S.p.A.; European Medicines Agency (EMA); Exponent; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Monsanto Company

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • International Prevention Research Institute (iPRI)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Icahn Medical Institute Floor 3rd Floor Room 3-55
1425 Madison Avenue
New York, NY 10029

Tel: 212-659-1474